Sanofi to focus on conventional protein-based Covid vaccine

 

SANOFI announced that it is dropping plans for its mRNA-based Covid-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna in using the technology to fight the pandemic. – Reuters (29 September 2021). “The move highlights the challenges of competing with pioneer BioNTech, which rose from obscurity through its alliance with pharma major Pfizer in 2020. They delivered nearly 1.5-bn doses so far to become the Western world’s largest Covid-19 vaccine maker.”

Other news